01Dec
Americas Antitrust Review 2021
Covid-19 has made 2020 into a year like no other with ‘stay at home’ orders and working from home the new normal. Nonetheless, the tech and pharma industries continued to attract immense antitrust scrutiny, with daily reports in the media and pressure from politicians to address what some perceive to be anticompetitive mergers by digital platforms and pharmaceutical companies, even while innovation in both sectors continues at breakneck speed. In this article, we discuss some of the most...
By:
Cooley LLP
Related
Paul Singer’s Elliott Management hedge fund revealed a $3.2 billion stake in AT&T and, along with i...
Read More >
This month's key California employment law cases involve payment of wages, workplace conditions, pub...
Read More >
COVID-19 continues to present novel challenges and disruptions to the merger and acquisitions market...
Read More >
In “La La Land,” Damien Chazelle’s Oscar winning film, the audience thinks it has a formulaic Hol...
Read More >
No One Likes a Bad Deal- Sometimes an acquired company’s revenues and earnings decline substantial...
Read More >
Employers, beware. It has been reported that Immigration and Customs Enforcement has recently begun ...
Read More >